Abstract

The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expended drastically in the last two decades. The pharmaceutical and chemical industry in India is an extremely fragmented market with severe price competition and government price control. The Pharmaceutical Industry in India meets around 705 of the country‟s demand for bulk drugs, drug intermediates, pharmaceutical formulation, chemicals,tablets, orals and injectibles. There are approximately 250 large units and about 8000 small-scale units, which form the core of the Pharmaceutical Industry in India (including 5 central public sector units) Looking ahead, the worldwide pharma market is estimated to more than double to $1.3 billion by the year 2020.The Indian Pharmaceutical Industry is developing drastically every year. Hence an attempt has been made to analyze the profitability position of the industry withthe help of mean, standard deviation, co-efficient of variation, multiple regression, and analysis of variance. The increase in profitability will not only yield greater efficiency but also improve financial performance in future.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call